Message #8 From:
NewsBot Date: October 3, 2006 06:00:00 AM
CYDY News Dr. Dorothy H. Bray to Chair Scientific Advisory Board at CytoDyn
SANTA FE, N.M.--(BUSINESS WIRE)--Dorothy H. Bray, Ph.D., will chair the Scientific Advisory Board at
CytoDyn, Inc. (OTCBB:CYDY), the Company announced today. Dr. Bray has
garnered extensive experience in the development of drugs for HIV/AIDS
while serving in various senior positions at GlaxoSmithKline (NYSE:GSK)
and its predecessors, a leading provider of antiretroviral drugs.
Dr. Bray previously led an industry-driven international program of
several hundred international studies of HIV/AIDS therapy, including
over a hundred conducted in developing countries. She has been involved
in multiple international research programs including the DART trial,
the largest HIV therapy trial ever conducted in Africa, the CIPRA
projects funded by the U.S. National Institutes of Health, as well as
advising on multiple clinical development programs in the biotech
industry.
Dr. Bray received her Ph.D. from the School of Pharmacy at the
University of London in 1988, and her Master of Science in Biology at
the Jagiellonian University of Cracow, Poland, in 1979. Her awards and
scholarships include The Winston Churchill Traveling Fellowship to study
medicinal plants in Africa, The Sir Halley Stewart Trust Fellowship to
study natural medicinal products, and The Royal Society Scholarship to
study immunology in Paris. She serves as a reviewer for a number of
scientific journals.
CytoDyn is developing Cytolin®, targeted
immune therapy for HIV/AIDS that is designed to restore immune function
and that has produced encouraging data in pilot clinical trials. “We
believe Dr. Bray’s experience and expertise
will be valuable across our entire pipeline,”
said CytoDyn’s CEO Allen D. Allen. The Company’s
pipeline includes a polyvalent family of DNA-based pre-vaccines for
influenza, and a product, Formaxycin™, that is
intended to treat pre-cancerous conditions of the skin based upon a
natural product long used by traditional healers in Africa.
Disclaimer
The information about Dr. Bray contained in this release was provided by
Dr. Bray and is relied on by the Company in good faith. Although Dr. Bray’s
credentials in the field of HIV/AIDS are well known among experts in
that field, the Company has made no independent effort to confirm this
information. There can be no assurance that the efforts of Dr. Bray on
behalf of the Company, if any, will produce positive results for the
Company or increase its value.
